Expression	NN
of	IN
suppressor-of-cytokine-signaling-1	NN
in	IN
the	DT
peripheral	JJ
blood	NN
of	IN
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
.	.

BACKGROUND	NN
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
progressive	JJ
diffuse	JJ
parenchymal	JJ
disease	NN
with	IN
a	DT
poor	JJ
prognosis	NN
.	.

A	DT
variety	NN
of	IN
cytokines	NNS
and	CC
chemokines	NNS
are	VBP
involved	VBN
in	IN
its	PRP$
pathophysiology	NN
.	.

The	DT
aim	NN
of	IN
this	DT
study	NN
was	VBD
to	TO
evaluate	VB
the	DT
clinical	JJ
features	NNS
in	IN
IPF	NN
patients	NNS
with	IN
the	DT
expression	NN
of	IN
suppressor-of-cytokine-signaling-1	NN
(	(
SOCS-1	NN
)	)
,	,
which	WDT
acts	VBZ
as	IN
a	DT
negative	JJ
regulator	NN
of	IN
cytokine	NN
signaling	NN
.	.

METHODS	NNS
:	:
IPF	NN
patients	NNS
(	(
n	NN
=	JJ
20	CD
)	)
and	CC
healthy	JJ
controls	NNS
(	(
n	NN
=	JJ
16	CD
)	)
were	VBD
included	VBN
in	IN
this	DT
study	NN
.	.

The	DT
expression	NN
of	IN
SOCS-1	NN
was	VBD
analyzed	VBN
in	IN
peripheral	JJ
blood	NN
mononuclear	JJ
cells	NNS
(	(
PBMC	NN
)	)
of	IN
subjects	NNS
using	VBG
RT-PCR	NN
.	.

Interleukin	NN
4	CD
(	(
IL-4	NN
)	)
,	,
transforming-growth-factor-b1	NN
(	(
TGF-b1	NN
)	)
and	CC
type	NN
I	CD
collagen	NN
expression	NN
were	VBD
also	RB
analyzed	VBN
in	IN
each	DT
individual	NN
using	VBG
enzyme-linked	JJ
immunosorbent	JJ
assay	NN
(	(
ELISA	NN
)	)
.	.

The	DT
clinical	JJ
characteristics	NNS
of	IN
IPF	NN
patients	NNS
were	VBD
delineated	VBN
.	.

These	DT
results	NNS
were	VBD
analyzed	VBN
by	IN
SPSS13	NN
.0	CD
statistics	NNS
software	NN
.	.

RESULTS	NNS
:	:
SOCS-1	NN
mRNA	NN
expression	NN
was	VBD
significantly	RB
decreased	VBN
in	IN
the	DT
PBMC	NN
of	IN
IPF	NN
patients	NNS
compared	VBN
with	IN
healthy	JJ
controls	NNS
;	:
serum	NN
levels	NNS
of	IN
IL-4	NN
and	CC
TGF-b1	NN
were	VBD
higher	JJR
in	IN
IPF	NN
patients	NNS
.	.

The	DT
patients	NNS
with	IN
lower	JJR
expression	NN
of	IN
SOCS-1	NN
developed	VBD
lower	JJR
percentage	NN
of	IN
forced	JJ
vital	JJ
capacity	NN
(	(
FVC	NN
%	NN
)	)
and	CC
DLCO/VA	NN
.	.

A	DT
patients	NNS
'	POS
SOCS-1	NN
mRNA	NN
level	NN
was	VBD
negatively	RB
correlated	VBN
with	IN
serum	NN
levels	NNS
of	IN
IL-4	NN
,	,
and	CC
negatively	RB
correlated	VBD
with	IN
their	PRP$
high-resolution	JJ
computed	VBN
tomography	NN
(	(
HRCT	NN
)	)
scores	NNS
.	.

CONCLUSIONS	NNS
:	:
SOCS-1	NN
mRNA	NN
can	MD
be	VB
detected	VBN
in	IN
PBMC	NN
,	,
and	CC
it	PRP
is	VBZ
down-regulated	VBN
in	IN
IPF	NN
patients	NNS
.	.

The	DT
expression	NN
of	IN
SOCS-1	NN
is	VBZ
associated	VBN
with	IN
the	DT
severity	NN
of	IN
IPF	NN
patients	NNS
'	POS
symptoms	NNS
,	,
so	IN
it	PRP
might	MD
be	VB
the	DT
predictor	NN
of	IN
disease	NN
severity	NN
.	.

SOCS-1	NN
might	MD
play	VB
an	DT
important	JJ
role	NN
in	IN
IPF	NN
by	IN
reducing	VBG
the	DT
expression	NN
of	IN
the	DT
T	NN
helper	NN
type	NN
2	CD
(	(
Th2	NN
)	)
cell-related	JJ
cytokine	NN
IL-4	NN
.	.

